Related references
Note: Only part of the references are listed.Simultaneous Inhibition of Protein Kinase CK2 and Dihydrofolate Reductase Results in Synergistic Effect on Acute Lymphoblastic Leukemia Cells
Patrycja Winska et al.
ANTICANCER RESEARCH (2019)
Role of protein kinase CK2 in antitumor drug resistance
Christian Borgo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Rational drug-design approach supported with thermodynamic studies - a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2
Maria Winiewska-Szajewska et al.
SCIENTIFIC REPORTS (2019)
Does the partial molar volume of a solute reflect the free energy of hydrophobic solvation?
Anna Szymaniec-Rutkowska et al.
JOURNAL OF MOLECULAR LIQUIDS (2019)
ALKBH overexpression in head and neck cancer: potential target for novel anticancer therapy
Tomas Pilzys et al.
SCIENTIFIC REPORTS (2019)
Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors
Barbara Guerra et al.
PHARMACEUTICALS (2019)
Therapeutic targeting of CK2 in acute and chronic leukemias
F. Buontempo et al.
LEUKEMIA (2018)
Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit
Andrea Baier et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells
Jung-Il Jung et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Novel (S)-1,3,4,12a-tetrahydropyrazino[2,1-c][1,4]benzodiazepine-6,12 (2H,11H)-dione derivatives: Selective inhibition of MV-4-11 biphenotypic B myelomonocytic leukemia cells' growth is accompanied by reactive oxygen species overproduction and apoptosis
Adam Mieczkowski et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Effect of Simultaneous Inhibition of Protein Kinase CK2 and Thymidylate Synthase in Leukemia and Breast Cancer Cells
Patrycja Winska et al.
ANTICANCER RESEARCH (2018)
Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia
Anna Richter et al.
BMC CANCER (2018)
2′-Deoxy-2′-azidonucleoside analogs: synthesis and evaluation of antitumor and antimicrobial activity
Adam Mieczkowski et al.
CHEMICAL PAPERS (2018)
Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Ramon Colomer et al.
CURRENT DRUG TARGETS (2017)
Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α', the catalytic subunits of CK2
Andrea Baier et al.
PHYTOCHEMISTRY (2017)
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Melissa M. J. Chua et al.
PHARMACEUTICALS (2017)
Synthesis and Investigation of the Antitumor Properties of Novel, Bicyclic Furopyrimidine, Pyrrolopyrimidine and Pyrimidopyridazine Nucleoside Analogues
Adam Mieczkowski et al.
SYNTHESIS-STUTTGART (2016)
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB
Francesca Buontempo et al.
ONCOTARGET (2016)
In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification
Jolanta D. Zolnierczyk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
The role of natural polyphenols in cell signaling and cytoprotection against cancer development
Hanna Lewandowska et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
A mild and efficient approach to the 6H-oxazolo[3,2-f]pyrimidine-5,7-dione scaffold via unexpected rearrangement of 2,3-dihydropyrimido[6,1-b][1,5,3]dioxazepine-7,9(5H,8H)-diones: synthesis, crystallographic studies, and cytotoxic activity screening
Adam Mieczkowski et al.
TETRAHEDRON LETTERS (2016)
The Fascinating Effects of Baicalein on Cancer: A Review
Hui Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures
Barbara Guerra et al.
ACS CHEMICAL BIOLOGY (2015)
Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2α
Maria Winiewska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Synergistic cytotoxic effects of bortezomib and ck2 inhibitor cx-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the proapoptotic NF-κb
F. Buontempo et al.
EUROPEAN JOURNAL OF CANCER (2015)
Setup and validation of shake-flask procedures for the determination of partition coefficients (logD) from low drug amounts
Axel Andres et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Bicyclic cytarabine analogues: synthesis and investigation of antitumor properties of novel, 6-aryl- and 6-alkyl-3H-pyrrolo[2,3-d] pyrimidin-2(7H)-one arabinosides
Adam Mieczkowski et al.
TETRAHEDRON (2015)
Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α
Jie Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3-derived sphere-forming cells
Ai-Qiong Tang et al.
MOLECULAR MEDICINE REPORTS (2015)
Cheburator Software for Automatically Calculating Drug Inhibitory Concentrations from In Vitro Screening Assays
Dmitry Nevozhay
PLOS ONE (2014)
Druggability of the CK2 inhibitor CX-4945 as an anticancer drug and beyond
Jiyeon Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight
Graziano Lolli et al.
BIOCHEMISTRY (2012)
Comparative Studies on the Interaction of Genistein, 8-Chlorogenistein, and 3′,8-Dichlorogenistein with Bovine Serum Albumin
Ji Zhang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90
Ming Zhao et al.
MOLECULAR CANCER (2011)
Flavonoids as Protein Kinase Inhibitors for Cancer Chemoprevention: Direct Binding and Molecular Modeling
De-Xing Hou et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Natural Polyphenols that Display Anticancer Properties through Inhibition of Kinase Activity
D. Lamoral-Theys et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Casein Kinase II: An attractive target for anti-cancer drug design
Ismail Muhamad Hanif et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8
Elmar Krieger et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?
Andrea Bortolato et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
Silvio E. Perea et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways
Sonia Ramos
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
New insights on the anticancer properties of dietary polyphenols
P. Fresco et al.
MEDICINAL RESEARCH REVIEWS (2006)
Quantum mechanical continuum solvation models
J Tomasi et al.
CHEMICAL REVIEWS (2005)
Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis
M Yamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
New developments in the polarizable continuum model for quantum mechanical and classical calculations on molecules in solution
M Cossi et al.
JOURNAL OF CHEMICAL PHYSICS (2002)
Share Paper
